InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by COOPER WARREN D, Director. Director active across 1 company, notably Zynerba Pharmaceuticals, Inc.. In total, 5 disclosures have been recorded. History available since 3 August 2021. The latest transaction was filed on 13 June 2023 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations5 total
27,954 sharesCommon StockSEC:0001140361-23-047731:0
47,824 shares0Common StockSEC:0001062993-23-013663:0
23,109 shares0Common StockSEC:0001062993-22-015038:0
5,000 shares0Common StockSEC:0001192482-21-000643:0
5,000 shares0Common StockSEC:0001192482-21-000643
5 of 5 declarations
About COOPER WARREN D
Warren D. Cooper is a Board Member at Zynerba Pharmaceuticals, Inc. He is involved in governance and strategic decision-making. With expertise in the pharmaceutical sector, Warren contributes to innovation and growth within the company.
